Chadwick Hales MD, PhD

Department of Neurology
Associate Professor

(404) 727-2455
cmhales@emory.edu

Academic Appointment

Assistant Professor, Neurology, Emory University

Education

Degrees

MD, PhD from Medical College of Georgia
BS from University of Georgia

Research

Focus

As a physician scientist who sees patients with cognitive problems in clinic weekly, I am dedicated to advancing our understanding of the basic cellular mechanisms of aging and in neurodegenerative disorders like Alzheimers disease (AD) and frontotemporal dementia. I am also motivated, being personally touched by frontotemporal dementia and having watched my grandfather slowly succumb to the indolent neurodegeneration of AD while my grandmother suffered by his side.

Publications

Spliceosome protein alterations differentiate hubs of the default mode connectome during the progression of Alzheimer's disease.
Brain Pathol Page(s): e70004
03/23/2025 Authors: Perez SE; Nadeem M; He B; Miguel JC; Moreno DG; Moreno-Rodriguez M; Malek-Ahmadi M; Hales CM; Mufson EJ
Neuropsychiatric symptoms cluster and fluctuate over time in behavioral variant frontotemporal dementia.
Psychiatry Clin Neurosci
03/13/2025 Authors: Morrow CB; Kamath V; Dickerson BC; Eldaief M; Rezaii N; Wong B; McGinnis S; Darby R; Staffaroni AM; Lapid MI
Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disorders.
Mol Neurodegener Volume: 20 Page(s): 30
03/12/2025 Authors: Sheth U; ijerstedt L; Heckman MG; White LJ; Heuer HW; Lario Lago A; Forsberg LK; Faber KM; Foroud TM; Rademakers R
Alzheimer's Disease Diagnosis and Management in the Age of Amyloid Monoclonal Antibodies.
Med Clin North Am Volume: 109 Page(s): 463 - 483
03/01/2025 Authors: Hales CM
Stratifying risk of Alzheimer's disease in healthy middle-aged individuals with machine learning.
Brain Commun Volume: 7 Page(s): fcaf121
01/01/2025 Authors: Tandon R; Zhao L; Watson CM; Sarkar N; Elmor M; Heilman C; Sanders K; Hales CM; Yang H; Loring DW
Lower Prevalence of Asymptomatic Alzheimer's Disease Among Healthy African Americans.
Ann Neurol Volume: 96 Page(s): 463 - 475
09/01/2024 Authors: Lah JJ; Tian G; Risk BB; Hanfelt JJ; Wang L; Zhao L; Hales CM; Johnson ECB; Elmor MB; Malakauskas SJ
Proteomic networks of gray and white matter reveal tissue-specific changes in human tauopathy.
Ann Clin Transl Neurol Volume: 11 Page(s): 2138 - 2152
08/01/2024 Authors: Johnson AG; Dammer EB; Webster JA; Duong DM; Seyfried NT; Hales CM
Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency.
Sci Transl Med Volume: 16 Page(s): eadl3758
06/26/2024 Authors: Pluvinage JV; Ngo T; Fouassier C; McDonagh M; Holmes BB; Bartley CM; Kondapavulur S; Hurabielle C; Bodansky A; Pai V
APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer's disease pathology.
Neuron Volume: 112 Page(s): 1110 - 1116.e5
04/03/2024 Authors: Chemparathy A; Le Guen Y; Chen S; Lee E-G; Leong L; Gorzynski JE; Jensen TD; Ferrasse A; Xu G; Xiang H
Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism.
Sci Rep Volume: 13 Page(s): 13752
08/23/2023 Authors: Borkowski K; Seyfried NT; Arnold M; Lah JJ; Levey AI; Hales CM; Dammer EB; Blach C; Louie G; Kaddurah-Daouk R
Literature-Based Discovery Predicts Antihistamines Are a Promising Repurposed Adjuvant Therapy for Parkinson's Disease.
Int J Mol Sci Volume: 24
08/02/2023 Authors: Tandra G; Yoone A; Mathew R; Wang M; Hales CM; Mitchell CS
APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer's Disease pathology.
medRxiv
07/24/2023 Authors: Chemparathy A; Guen YL; Chen S; Lee E-G; Leong L; Gorzynski J; Xu G; Belloy M; Kasireddy N; Tauber AP
Predictors of Cognitive Decline in Healthy Middle-Aged Individuals with Asymptomatic Alzheimer's Disease.
Res Sq
02/28/2023 Authors: Tandon R; Zhao L; Watson CM; Elmor M; Heilman C; Sanders K; Hales CM; Yang H; Loring DW; Goldstein FC
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment.
Brain Volume: 145 Page(s): 1924 - 1938
06/30/2022 Authors: Levey AI; Qiu D; Zhao L; Hu WT; Duong DM; Higginbotham L; Dammer EB; Seyfried NT; Wingo TS; Hales CM
The Georgia Memory Net: Implementation of a statewide program to diagnose and treat Alzheimer's disease and related dementias.
J Am Geriatr Soc Volume: 70 Page(s): 1257 - 1267
04/01/2022 Authors: Bender AA; McIntosh RL; Sudduth S; Harris M; Tuckey K; Morgan JC; Jungerman JM; Cox A; Moore MA; Ingram B
Glial profiling of human tauopathy brain demonstrates enrichment of astrocytic transcripts in tau-related frontotemporal degeneration.
Neurobiol Aging Volume: 112 Page(s): 55 - 73
04/01/2022 Authors: Johnson AG; Webster JA; Hales CM
Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer's disease.
Alzheimers Res Ther Volume: 13 Page(s): 149
09/06/2021 Authors: Borkowski K; Pedersen TL; Seyfried NT; Lah JJ; Levey AI; Hales CM; Dammer EB; Blach C; Louie G; Kaddurah-Daouk R
Urokinase-type plasminogen activator promotes N-cadherin-mediated synaptic recovery in the ischemic brain.
J Cereb Blood Flow Metab Volume: 41 Page(s): 2381 - 2394
09/01/2021 Authors: Diaz A; Merino P; McCann P; Yepes MA; Quiceno LG; Torre E; Tomkins A; Zhang X; Hales CM; Tong FC
A proteomic network approach resolves stage-specific molecular phenotypes in chronic traumatic encephalopathy.
Mol Neurodegener Volume: 16 Page(s): 40
06/25/2021 Authors: Gutierrez-Quiceno L; Dammer EB; Johnson AG; Webster JA; Shah R; Duong D; Yin L; Seyfried NT; Alvarez VE; Stein TD
5-hydroxymethylcytosine is dynamically regulated during forebrain organoid development and aberrantly altered in Alzheimer's disease.
Cell Rep Volume: 35 Page(s): 109042
04/27/2021 Authors: Kuehner JN; Chen J; Bruggeman EC; Wang F; Li Y; Xu C; McEachin ZT; Li Z; Chen L; Hales CM
Cell-type-specific profiling of human cellular models of fragile X syndrome reveal PI3K-dependent defects in translation and neurogenesis.
Cell Rep Volume: 35 Page(s): 108991
04/13/2021 Authors: Raj N; McEachin ZT; Harousseau W; Zhou Y; Zhang F; Merritt-Garza ME; Taliaferro JM; Kalinowska M; Marro SG; Hales CM
Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis.
JAMA Neurol Volume: 77 Page(s): 1420 - 1429
11/01/2020 Authors: Dubey D; Wilson MR; Clarkson B; Giannini C; Gandhi M; Cheville J; Lennon VA; Eggers S; Devine MF; Mandel-Brehm C
Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36.
Neuron Volume: 107 Page(s): 292 - 305.e6
07/22/2020 Authors: McEachin ZT; Gendron TF; Raj N; Garca-Murias M; Banerjee A; Purcell RH; Ward PJ; Todd TW; Merritt-Garza ME; Jansen-West K
Clinical/ Immunopathological Presentations and Antigen-specific CD8+T Cell Responses in Paraneoplastic Autoimmune KLHL11 Encephalitis
Volume: 94
04/14/2020 Authors: Dubey D; Wilson M; Giannini C; Gandhi M; Cheville J; Lennon V; Clarkson B; Eggers S; Devine M; Mandel-Brehm C
CRISPR-mediated gene correction links the ATP7A M1311V mutations with amyotrophic lateral sclerosis pathogenesis in one individual.
Commun Biol Volume: 3 Page(s): 33
01/20/2020 Authors: Yun Y; Hong S-A; Kim K-K; Baek D; Lee D; Londhe AM; Lee M; Yu J; McEachin ZT; Bassell GJ
TDP-43 cytoplasmic inclusion formation in C9orf72-associated FTLD/ALS
Volume: 92
04/09/2019 Authors: Lee S; Asress S; Hales C; Vizcarra J; Gutman D; Gearing M; Chin L-S; Li L; Glass J
TDP-43 cytoplasmic inclusion formation is disrupted in C9orf72-associated amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
Brain Commun Volume: 1 Page(s): fcz014
01/01/2019 Authors: Lee SM; Asress S; Hales CM; Gearing M; Vizcarra JC; Fournier CN; Gutman DA; Chin L-S; Li L; Glass JD
Proteomic Changes in Frontotemporal Lobar Degeneration Due to Microtubule Associated Protein Tau (MAPT) Mutations
Volume: 84 Page(s): S161 - S161
10/01/2018 Authors: Hales C; Duc D; Seyfried N; Webster J; Levey A; Lah J; Dammer E
Improving Alzheimer's Disease Care for the Citizens of Georgia: The Georgia Memory Network
Volume: 84 Page(s): S69 - S69
10/01/2018 Authors: Hales C; Dillard R; Sudduth S; Medders L; Loring D; Hepburn K; Johnson T; Humberstone S; Levey A; Lah J
Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.
Mol Neurodegener Volume: 13 Page(s): 34
06/28/2018 Authors: Rangaraju S; Dammer EB; Raza SA; Gao T; Xiao H; Betarbet R; Duong DM; Webster JA; Hales CM; Lah JJ
TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.
Nat Neurosci Volume: 21 Page(s): 228 - 239
02/01/2018 Authors: Chou C-C; Zhang Y; Umoh ME; Vaughan SW; Lorenzini I; Liu F; Sayegh M; Donlin-Asp PG; Chen YH; Duong DM
Characterization of Detergent Insoluble Proteome in Chronic Traumatic Encephalopathy.
J Neuropathol Exp Neurol Volume: 77 Page(s): 40 - 49
01/01/2018 Authors: Cherry JD; Zeineddin A; Dammer EB; Webster JA; Duong D; Seyfried NT; Levey AI; Alvarez VE; Huber BR; Stein TD
Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.
Mol Neurodegener Volume: 12 Page(s): 76
10/24/2017 Authors: Konrad C; Kawamata H; Bredvik KG; Arreguin AJ; Cajamarca SA; Hupf JC; Ravits JM; Miller TM; Maragakis NJ; Hales CM
Comparison of detergent-insoluble proteome changes in autosomal dominant Alzheimer's disease brain to late onset AD and transgenic rodents
Volume: 88
04/18/2017 Authors: Hales C; Dammer E; Duong D; Gearing M; Cohen R; Wingo T; Lah J; Levey A; Seyfried N
A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease.
Cell Syst Volume: 4 Page(s): 60 - 72.e4
01/25/2017 Authors: Seyfried NT; Dammer EB; Swarup V; Nandakumar D; Duong DM; Yin L; Deng Q; Nguyen T; Hales CM; Wingo T
Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
Proteomics Volume: 16 Page(s): 3042 - 3053
12/01/2016 Authors: Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI
NADPH Dehydrogenase Quinone 1 (NQO1) Demonstrates Increased Expression and Pathologic Aggregation in Glial Cells in Chronic Traumatic Encephalopathy
Volume: 80 Page(s): S195 - S195
10/01/2016 Authors: Hales C; Zeineddin A; Webster J; Giuliano J; Duong D; Seyfried N; Dammer E; Mckee A; Levey A; Lah J
A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
Dis Model Mech Volume: 9 Page(s): 927 - 939
09/01/2016 Authors: Preininger MK; Jha R; Maxwell JT; Wu Q; Singh M; Wang B; Dalal A; Mceachin ZT; Rossoll W; Hales CM
Trehalose enhances progranulin expression in progranulin-deficient patient cells and mouse brain
Volume: 138 Page(s): 249 - 249
08/01/2016 Authors: Holler C; Taylor G; McEachin Z; Deng Q; Watkins W; Hudson K; Easley C; Hu W; Hales C; Rossoll W
Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia.
Mol Neurodegener Volume: 11 Page(s): 46
06/24/2016 Authors: Holler CJ; Taylor G; McEachin ZT; Deng Q; Watkins WJ; Hudson K; Easley CA; Hu WT; Hales CM; Rossoll W
A Comparative Analysis of the Insoluble Brain Proteome in Alzheimer's Disease, Chronic Traumatic Encephalopathy and Frontotemporal Dementia
Volume: 86
04/05/2016 Authors: Hales C; Dammer E; Duong D; Webster J; Zeineddin A; Seyfried N; Lah J
A Comparative Analysis of the Insoluble Brain Proteome in Alzheimer's Disease, Chronic Traumatic Encephalopathy and Frontotemporal Dementia
Volume: 86
04/05/2016 Authors: Hales C; Dammer E; Duc D; Webster J; Zeineddin A; Seyfried N; Lah J
CSF complement 3 and factor H are staging biomarkers in Alzheimer's disease.
Acta Neuropathol Commun Volume: 4 Page(s): 14
02/17/2016 Authors: Hu WT; Watts KD; Tailor P; Nguyen TP; Howell JC; Lee RC; Seyfried NT; Gearing M; Hales CM; Levey AI
The Cognitive Impairment in Stroke Screener (CISS) Tool: an Improved Screening Tool to Detect Cognitive Impairment Early Among Stroke Patients
Volume: 47
02/01/2016 Authors: Bonner J; Rangaraju S; Schleuse S; Lampert S; Sinsley D; Javalkar V; Gebru MW; Brasher C; Dunn J; Bryant K
Aggregation properties of the small nuclear ribonucleoprotein U1-70K in Alzheimer disease.
J Biol Chem Volume: 289 Page(s): 35296 - 35313
12/19/2014 Authors: Diner I; Hales CM; Bishof I; Rabenold L; Duong DM; Yi H; Laur O; Gearing M; Troncoso J; Thambisetty M
Late-stage CTE pathology in a retired soccer player with dementia.
Neurology Volume: 83 Page(s): 2307 - 2309
12/01/2014 Authors: Hales C; Neill S; Gearing M; Cooper D; Glass J; Lah J
Integrated approaches for analyzing U1-70K cleavage in Alzheimer's disease.
J Proteome Res Volume: 13 Page(s): 4526 - 4534
11/07/2014 Authors: Bai B; Chen P-C; Hales CM; Wu Z; Pagala V; High AA; Levey AI; Lah JJ; Peng J
Small Nuclear Ribonucleoproteins (snRNPs) Aggregate in Chronic Traumatic Encephalopathy Suggesting Shared Mechanism with Alzheimer's Disease
Volume: 76 Page(s): S116 - S116
10/01/2014 Authors: Hales CM; Mckee AC; Levey AI; Lah JJ
Aggregates of small nuclear ribonucleic acids (snRNAs) in Alzheimer's disease.
Brain Pathol Volume: 24 Page(s): 344 - 351
07/01/2014 Authors: Hales CM; Dammer EB; Diner I; Yi H; Seyfried NT; Gearing M; Glass JD; Montine TJ; Levey AI; Lah JJ
Fat mass and obesity-associated (FTO) protein interacts with CaMKII and modulates the activity of CREB signaling pathway.
Hum Mol Genet Volume: 23 Page(s): 3299 - 3306
06/15/2014 Authors: Lin L; Hales CM; Garber K; Jin P
U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer's disease due to autosomal dominant genetic mutations and trisomy 21.
Mol Neurodegener Volume: 9 Page(s): 15
04/28/2014 Authors: Hales CM; Seyfried NT; Dammer EB; Duong D; Yi H; Gearing M; Troncoso JC; Mufson EJ; Thambisetty M; Levey AI
Pharmacologic inhibition of ROCK2 suppresses amyloid- production in an Alzheimer's disease mouse model.
J Neurosci Volume: 33 Page(s): 19086 - 19098
12/04/2013 Authors: Herskowitz JH; Feng Y; Mattheyses AL; Hales CM; Higginbotham LA; Duong DM; Montine TJ; Troncoso JC; Thambisetty M; Seyfried NT
Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP.
Neurology Volume: 81 Page(s): 1945 - 1952
11/26/2013 Authors: Hu WT; Watts K; Grossman M; Glass J; Lah JJ; Hales C; Shelnutt M; Van Deerlin V; Trojanowski JQ; Levey AI
Abnormal gephyrin immunoreactivity associated with Alzheimer disease pathologic changes.
J Neuropathol Exp Neurol Volume: 72 Page(s): 1009 - 1015
11/01/2013 Authors: Hales CM; Rees H; Seyfried NT; Dammer EB; Duong DM; Gearing M; Montine TJ; Troncoso JC; Thambisetty M; Levey AI
U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease.
Proc Natl Acad Sci U S A Volume: 110 Page(s): 16562 - 16567
10/08/2013 Authors: Bai B; Hales CM; Chen P-C; Gozal Y; Dammer EB; Fritz JJ; Wang X; Xia Q; Duong DM; Street C
Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration.
Proc Natl Acad Sci U S A Volume: 110 Page(s): 7778 - 7783
05/07/2013 Authors: Xu Z; Poidevin M; Li X; Li Y; Shu L; Nelson DL; Li H; Hales CM; Gearing M; Wingo TS
From frontotemporal lobar degeneration pathology to frontotemporal lobar degeneration biomarkers.
Int Rev Psychiatry Volume: 25 Page(s): 210 - 220
04/01/2013 Authors: Hales CM; Hu WT
Clinical Tissue Proteomics Identifies the U1 Small Nuclear Ribonucleoprotein Complex in Alzheimer Disease Pathology
MOLECULAR BIOLOGY OF THE CELL Volume: 24
01/01/2013 Authors: Chen P-C; Bai B; Hales C; Gozal YM; Li Y; Dammer EB; Cantero G; Seyfried NT; Sun YE; Mufson EJ
Gephyrin Plaques Identified in Frontal Cortex of Alzheimer's Disease Brains
Volume: 72 Page(s): S43 - S43
01/01/2012 Authors: Hales CM; Rees H; Lah JJ; Levey AI; Wingo T
Stimulus-evoked high frequency oscillations are present in neuronal networks on microelectrode arrays.
Front Neural Circuits Volume: 6 Page(s): 29
01/01/2012 Authors: Hales CM; Zeller-Townson R; Newman JP; Shoemaker JT; Killian NJ; Potter SM
How to culture, record and stimulate neuronal networks on micro-electrode arrays (MEAs).
J Vis Exp
05/30/2010 Authors: Hales CM; Rolston JD; Potter SM
MARK2/EMK1/Par-1Balpha phosphorylation of Rab11-family interacting protein 2 is necessary for the timely establishment of polarity in Madin-Darby canine kidney cells.
Mol Biol Cell Volume: 17 Page(s): 3625 - 3637
08/01/2006 Authors: Ducharme NA; Hales CM; Lapierre LA; Ham A-JL; Oztan A; Apodaca G; Goldenring JR
Identification of a kinase which phosphorylates Rab11-FIP2 on serine 227
Volume: 15 Page(s): 198A - 198A
11/01/2004 Authors: Ducharme NA; Hales CM; Lapierre LA; Crowe JE; Goldenring JR
Dynamics of the apical plasma membrane recycling system during cell division.
Traffic Volume: 4 Page(s): 681 - 693
07/01/1995 Authors: Hobdy-Henderson KC; Hales CM; Lapierre LA; Cheney RE; Goldenring JR
Rab11 family interacting protein 2 associates with Myosin Vb and regulates plasma membrane recycling.
J Biol Chem Volume: 277 Page(s): 50415 - 50421
12/27/2002 Authors: Hales CM; Vaerman J-P; Goldenring JR
Identification of a kinase activity phosphorylating Rab11-FIP2
Volume: 13 Page(s): 508A - 508A
11/01/2002 Authors: Hales CM; Goldenring JR
Rab11 interacting proteins as regulators of parietal cell apical recycling: Lessons from the master
Page(s): 335 - 347
01/01/2002 Authors: Goldenring JR; Hales CM; Lapierre LA
Regulation of the recycling system during cell division
MOLECULAR BIOLOGY OF THE CELL Volume: 12 Page(s): 216A - 217A
01/01/2001 Authors: HobdyHenderson KC; Griner JD; Hales CM; Lapierre LA
Myosin Vb tail associates with Rab11-family interacting protein 2 (Rab11-FIP2)
MOLECULAR BIOLOGY OF THE CELL Volume: 12 Page(s): 90A - 90A
11/01/2001 Authors: Hales CM; Hobdy-Henderson KC; Zimmerman CF; Navarre J; Dorn M; Lapierre LA; Goldenring JR
Direct interaction of the spinal muscular atrophy disease protein SMN with the small nucleolar RNA-associated protein fibrillarin.
J Biol Chem Volume: 276 Page(s): 38645 - 38651
10/19/2001 Authors: Jones KW; Gorzynski K; Hales CM; Fischer U; Badbanchi F; Terns RM; Terns MP
Identification and characterization of a family of Rab11-interacting proteins.
J Biol Chem Volume: 276 Page(s): 39067 - 39075
10/19/2001 Authors: Hales CM; Griner R; Hobdy-Henderson KC; Dorn MC; Hardy D; Kumar R; Navarre J; Chan EK; Lapierre LA; Goldenring JR
Myosin vb is associated with plasma membrane recycling systems.
Mol Biol Cell Volume: 12 Page(s): 1843 - 1857
06/01/2001 Authors: Lapierre LA; Kumar R; Hales CM; Navarre J; Bhartur SG; Burnette JO; Provance DW; Mercer JA; Bhler M; Goldenring JR
Rab11a-FIP1 and Rab11a-FIP2 translocate to the secretory canaliculus of parietal cells upon stimulation with histamine
GASTROENTEROLOGY Volume: 120 Page(s): A103 - A103
04/01/2001 Authors: Hales CM; Lapierre LA; Dorn M; Griner R; Goldenring JR
Novel Rab 11 interacting proteins: RAB11-FIP1 and Rab11-FIP2
FASEB JOURNAL Volume: 15 Page(s): A499 - A499
03/07/2001 Authors: Hales CM; Griner R; Navarre J; Lapierre L; Goldenring JR
Smooth muscle relaxation during the initiation vs. the sustained phase of contraction
Volume: 14 Page(s): A663 - A663
03/15/2000 Authors: Hales C; Brophy C

Directory section navigation

Profile

Chadwick Hales MD, PhD

Academic Appointment

Education

Degrees

Research

Focus

Publications